These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1739095)

  • 1. Silicon accumulation in dialysis patients.
    Gitelman HJ; Alderman FR; Perry SJ
    Am J Kidney Dis; 1992 Feb; 19(2):140-3. PubMed ID: 1739095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High fluoride exposure in hemodialysis patients.
    Bello VA; Gitelman HJ
    Am J Kidney Dis; 1990 Apr; 15(4):320-4. PubMed ID: 2321644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased silicon levels in dialysis patients due to high silicon content in the drinking water, inadequate water treatment procedures, and concentrate contamination: a multicentre study.
    D'Haese PC; Shaheen FA; Huraib SO; Djukanovic L; Polenakovic MH; Spasovski G; Shikole A; Schurgers ML; Daneels RF; Lamberts LV
    Nephrol Dial Transplant; 1995 Oct; 10(10):1838-44. PubMed ID: 8592591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silicon and aluminium interactions in haemodialysis patients.
    Parry R; Plowman D; Delves HT; Roberts NB; Birchall JD; Bellia JP; Davenport A; Ahmad R; Fahal I; Altmann P
    Nephrol Dial Transplant; 1998 Jul; 13(7):1759-62. PubMed ID: 9681724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure.
    MacPhee IA; Spreafico S; Bewick M; Davis C; Eastwood JB; Johnston A; Lee T; Holt DW
    Kidney Int; 2000 Mar; 57(3):1164-8. PubMed ID: 10720968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silicon-related syndrome in dialysis patients.
    Saldanha LF; Gonick HC; Rodriguez HJ; Marmelzat JA; Repique EV; Marcus CL
    Nephron; 1997; 77(1):48-56. PubMed ID: 9380238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silicon metabolism: the basic facts in renal failure.
    Berlyne G; Dudek E; Adler AJ; Rubin JE; Seidman M
    Kidney Int Suppl; 1985 Dec; 17():S175-7. PubMed ID: 3867790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silicon in chronic hemodialysis patients.
    Hosokawa S; Morinaga M; Nishitani H; Maeda T; Yoshida O
    ASAIO Trans; 1987; 33(3):260-4. PubMed ID: 3314921
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of plasma amino acid concentrations in end-stage renal disease patients on hemodialysis and peritoneal dialysis.
    Kim DH; Yang DH; Hong SY
    Korean J Intern Med; 1998 Feb; 13(1):33-40. PubMed ID: 9538629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum vanadium levels in chronic hemodialysis patients.
    Hosokawa S; Yoshida O
    Nephron; 1993; 64(3):388-94. PubMed ID: 8341383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary and serum silicon in normal and uraemic individuals.
    Dobbie JW; Smith MB
    Ciba Found Symp; 1986; 121():194-213. PubMed ID: 3743230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immediate effect of hemodialysis with cuprophane membrane and acetate containing dialysis fluid on respiratory function in patients with chronic renal failure].
    Wanic-Kossowska M
    Pol Tyg Lek; 1993 Feb 15-22; 48(7-8):175-7. PubMed ID: 8415262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased silicon levels in dialysis patients due to high silicon content in the drinking water, inadequate water treatment procedures, and concentrate contamination: a multicentre study.
    Birchall D; Bellia J; Roberts N
    Nephrol Dial Transplant; 1996 Jun; 11(6):1188-9. PubMed ID: 8966009
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxalate, silicon and vanadium in acquired cystic kidney disease.
    Marco-Franco JE; Torres VE; Nixon DE; Wilson DM; James EM; Bergstralh EJ; McCarthy JT
    Clin Nephrol; 1991 Feb; 35(2):52-8. PubMed ID: 2019015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowering postdialysis plasma sodium (conductivity) to increase sodium removal in volume-expanded hemodialysis patients: a pilot study using a biofeedback software system.
    Manlucu J; Gallo K; Heidenheim PA; Lindsay RM
    Am J Kidney Dis; 2010 Jul; 56(1):69-76. PubMed ID: 20303632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum ionic fluoride levels in haemodialysis and continuous ambulatory peritoneal dialysis patients.
    al-Wakeel JS; Mitwalli AH; Huraib S; al-Mohaya S; Abu-Aisha H; Chaudhary AR; al-Majed SA; Memon N
    Nephrol Dial Transplant; 1997 Jul; 12(7):1420-4. PubMed ID: 9249779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease.
    Evans AM; Faull RJ; Nation RL; Prasad S; Elias T; Reuter SE; Fornasini G
    Kidney Int; 2004 Oct; 66(4):1527-34. PubMed ID: 15458447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia in chronic renal failure patients: relation to tissue factor and platelet aggregation.
    Cetin O; Bekpinar S; Unlucerci Y; Turkmen A; Bayram C; Ulutin T
    Clin Nephrol; 2006 Feb; 65(2):97-102. PubMed ID: 16509458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.